Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Introduction
00:00 • 4min
Merck's Extortion Is a Good Idea
04:20 • 4min
The Constitutionality of the Government Forcing a Price on a Company
08:36 • 3min
Secondary Financing Activity in the Market
11:27 • 2min
Peritec, $462 Million Acquisition by Gurnet Point Capital and No-Hole Holdings
13:40 • 3min
Jacob Pleece's Tweet Caused the Stock to Drop 35%
16:18 • 6min
ASCO's Immunogen Survival Data
22:11 • 4min
The Four Decades of Immunogen's Success
26:35 • 4min
Diesel Pharmaceuticals: A Good Opportunity to Raise Money
30:48 • 3min
Replimium: The Biggest Stock Mover of the Conference
33:31 • 4min
CT DNA: A Biomarker of Therapeutic Effect
37:43 • 5min
What Is Happening on the M and A?
42:39 • 4min
The Impact of M&A on the Capital Markets
46:12 • 3min
The Future of Biotech in China
49:15 • 4min
The Impact of the 85% Discount to a Humira on Cancer
53:44 • 4min